Portfolio Update

RNS Number : 8187H
Intl. Biotechnology Trust PLC
25 June 2013
 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC      

                                                                                                                                   

                                                                                                                                              

Portfolio Update as at 31 May 2013                                                                                        

 

 

Total net assets

£163.8m

NAV per share

297.0p

Share price

258.5p

Total value of unquoted investments

£25.8m

Total number of portfolio companies

70

Cash

1% NAV

Cash committed and reserved to unquoted investments

(4.5%) NAV

 

                                                                                                                                              

Top Ten Holdings

                                                                                                                                                                                                                                                                    

Company Name

% NAV

Gilead

Amgen

Celgene

6.9

6.6

6.1

Alexion

5.0

Onyx

4.2

Biogen

3.9

Aptiv

3.6

Insulet

2.8

Regeneron

2.7

Achillion

2.4


-----------

Total

44.2

 

Geographical Allocation

%

United States & Canada

90

Europe

9

Cash

1


-----------

Total

100

 

                                                                                                                                                                                                                                                                    

Quoted/Unquoted allocation

%

Quoted

83

Unquoted

16

Cash

1


-----------

Total

100

                                                                                                   

 

BNP Paribas Secretarial Services Limited

Company Secretary

 

25 JUNE 2013


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUBDGDLCUDBGXU
Investor Meets Company
UK 100